NYSE · OSCR

Oscar Health, Inc.

$28.19 -$0.73 (-2.52%) 1D After hours

Key Metrics

$8.72B
Market cap
P/E · TTM
$13.30B
Revenue · TTM
−$39.43M
Net income
EPS · TTM $-0.13
Dividend yield
Free cash flow $2.80B
Beta · 1Y 1.57
EBITDA · TTM $2.45M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 4
    The stock moved +15.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 4
  • Apr 8
    The stock moved +12.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 8
  • Mar 30
    From its Mar 4 high, the share price fell 28%.

    Peak close $15.05 on Mar 4; trough close $10.85 on Mar 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -28%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$8.72B
Enterprise value$1.08B
Shares outstanding301.5M
52-wk range$10.69 – $33.10
Avg volume · 20D5.0M
Net cash $7.64B
Book value / share$5.44
IndustryHospital & Medical Service Plans
ExchangeNYSE
About Oscar Health, Inc.
IPO dateMar 3, 2021
Employees2305

Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.66
P/FCF3.11
EV/EBITDA443.15
EV/Sales0.08
Graham №

Profitability

Gross
Operating -0.2%
Net -0.3%
FCF 21.0%
ROE / ROIC -2.9% · 0.8%

Financial Health

Current ratio1.09
Quick ratio
Debt / equity0.26
Debt / EBITDA 176.23
Net cash $7.64B
Working capital$636.95M

Cash Flow · TTM

Operating CF $2.84B
Capex −$36.14M
Free cash flow $2.80B
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

1.8
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings